Miracle boosts transparency with automated insights

NASDAQ: DNTH

"Leveraging the capabilities of Miracle, we are now able to see our data in new and unexpected ways. The real-time insights provided enable Dianthus to make more informed, data-driven decisions and centralizing our incoming clinical data also allows us to work more efficiently and effectively across multiple functional groups. With Miracle’s intuitive interface and powerful capabilities, we now have a clearer understanding of our data which positions us well for the future."

Blake Potter

Director, Data Sciences
Dianthus Therapeutics

NASDAQ: VTGN

"It is fabulous to have access to up-to-the-minute data integrated across multiple platforms, making it so much easier for our team to monitor trial progress!"
‍

Maura Maria

Senior Director, Clinical Operations
Vistagen Therapeutics

NASDAQ: MLYS

"Mineralys had an urgent need for a platform to take in real-time clinical trial analytics, study site level output, aggregate recruitment, performance metrics and models.  Within a week, Miracle had us up and running. Within a month, we could identify opportunities to improve site performance, and in less than three months, we were seeing an impact on our performance goals."

David Rodman

Chief Medical Officer
Mineralys Therapeutics

NASDAQ: IKT

"The Miracle platform has been a game changer for Inhibikase Therapeutics. Beyond streamlining our recruitment information flow, which significantly reduced the time from participant inquiry to contact, we've expanded its utility to encompass drug supply monitoring and data quality review in a continuous manner. Having all this information in Miracle as a control room has not only enhanced our operational efficiency but has also injected more transparency into our clinical trial management process."

Chris Meyer

Vice President, Clinical Operations
Inhibikase Therapeutics

3 months

Runway Saved

"Miracle shined a giant light on the black box of clinical trial recruitment. Their customized real-time dashboard not only added transparency but also allowed us to understand where our recruitment efforts were effective and where they weren't, all without having to maintain traditional spreadsheet trackers combining data from our study website, EDC, and recruitment vendors. This level of visibility allowed our team to make rapid adjustments and achieve database lock three months ahead of schedule, effectively giving us back an additional quarter of runway."

Stewart Campbell

Chief Executive Officer
‍Axial Therapeutics